Karyopharm Therapeutics Free Cash Flow (Quarterly) Insights

Karyopharm Therapeutics Inc (KPTI)

1.05 -0.01 (-0.94%) USD | NASDAQ | Apr 26, 16:00

1.05 0.00 (0.00%) After-Hours: 19:38

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-18.58M
September 30, 2023	-29.53M
June 30, 2023	-25.70M
March 31, 2023	-18.91M
December 31, 2022	-26.84M
September 30, 2022	-28.41M
June 30, 2022	-35.14M
March 31, 2022	-59.28M
December 31, 2021	25.77M
September 30, 2021	-29.96M
June 30, 2021	-55.75M
March 31, 2021	-52.89M
December 31, 2020	-30.75M
September 30, 2020	-44.31M
June 30, 2020	-40.29M
March 31, 2020	-45.02M
December 31, 2019	-39.54M
September 30, 2019	-36.61M
June 30, 2019	-48.20M
March 31, 2019	-66.67M
December 31, 2018	-49.26M
September 30, 2018	-39.16M

Date	Value
June 30, 2018	-38.02M
March 31, 2018	-35.03M
December 31, 2017	-5.593M
September 30, 2017	-21.76M
June 30, 2017	-21.72M
March 31, 2017	-24.71M
December 31, 2016	-20.02M
September 30, 2016	-20.33M
June 30, 2016	-20.90M
March 31, 2016	-23.20M
December 31, 2015	-20.88M
September 30, 2015	-25.47M
June 30, 2015	-28.70M
March 31, 2015	-20.40M
December 31, 2014	-12.87M
September 30, 2014	-18.52M
June 30, 2014	-12.21M
March 31, 2014	-10.69M
December 31, 2013	-10.11M
September 30, 2013	-8.924M
June 30, 2013	-6.156M
March 31, 2013	-5.157M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-59.28M

Minimum

Mar 2022

25.77M

Maximum

Dec 2021

-33.68M

Average

-35.14M

Median

Jun 2022

Free Cash Flow (Quarterly) Benchmarks